Joint Intellectual Property Rights definition

Joint Intellectual Property Rights means any work under the Subcontract, which:

Joint Intellectual Property Rights has the meaning set forth in Section 7.1.2.

Joint Intellectual Property Rights means the Joint Program Know-How and Joint Program Patents.

Examples of Joint Intellectual Property Rights in a sentence

• The subject matter of which is capable of protection under domestic or foreign law, including but not limited to, patents, copyrights, trademarks, or mask works.B. As to Joint Intellectual Property Rights, in which SRNS has a joint ownership interest, the Subcontractor/Supplier agrees to negotiate in good faith with SRNS a Memorandum of Agreement to resolve issues of participation in protection and commercialization.

• The FDA could also limit or prevent the manufacture or distribution of the Company's products and has the power to require the recall of such products.

• The Parties may assign their respective ownership in the Joint Intellectual Property Rights only to such respective assignee(s) as are agreed between them after discussion.

• As to Joint Intellectual Property Rights, in which SRNS has a joint ownership interest, the Subcontractor/Supplier agrees to negotiate in good faith with SRNS a Memorandum of Agreement to resolve issues of participation in protection and commercialization.

• Subject to the licenses and rights of reference granted under Sections 4.1 and 4.2, and each Party’s exclusivity obligations in Section 4.5, each Party shall have the right to Exploit the Joint Intellectual Property Rights without a duty of seeking consent or accounting to the other Party.

More Definitions of Joint Intellectual Property Rights

Joint Intellectual Property Rights means any work under the Subcontract that:

Joint Intellectual Property Rights means collectively, Joint Patent and Joint Other Intellectual Property Rights (excluding Trademarks).

Joint Intellectual Property Rights has the meaning set forth in Section 7.1.2 (Ownership of Joint Patents and Joint Know-How).

Joint Intellectual Property Rights has the meaning set forth in Section 7.2.2. [*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.

Joint Intellectual Property Rights means any and all intellectual property rights that are directed to the Joint Intellectual Property and that result from work done jointly by the Parties under this Agreement, and which also arise under patent law, copyright law, industrial design rights law, semiconductor chip and mask work protection law, trade secret law, trademark law, unfair competition law, and any and all similar proprietary rights as may be in effect from time to time during the term of this Agreement, and any and all renewals, extensions, and restorations thereof, now or hereafter in force and effect worldwide.

Joint Intellectual Property Rights means all Intellectual Property Rights to Program Technology except Patent Rights to Program Technology.

Joint Intellectual Property Rights shall have the meaning set forth in Section 8.1.5. 1.1.73 “Joint Know-How” shall have the meaning set forth in Section 8.1.5. 1.1.74 “Joint Patents” shall have the meaning set forth in Section 8.1.5. 1.1.75 “Joint Steering Committee” or “JSC” shall have the meaning set forth in Section 6.1.1. 1.1.76 “Know-How” shall mean the Licensor Know-How, the Licensee Know-How and the Joint Know-How. 1.1.77 “Knowledge” shall mean the actual knowledge or good faith understanding of the vice presidents, senior vice presidents, president or chief executive officer of a Party of the facts and information then in their possession without any duty to conduct any investigation with respect to such facts and information and “Knowingly” shall mean, with respect to any action, to take such action with Knowledge. 1.1.78 “Licensed Compound” shall mean CP-4126 and any analog or derivative of CP-4126 developed by Licensor. 1.1.79 “Licensed Product” shall mean any oral and intravenous formulations of the Licensed Compound existing as of the Original Execution Date, and any formulations developed thereafter by or for Licensor or Licensee, and any other any form, mode of administration or dosage of a pharmaceutical composition or preparation that contains the Licensed Compound as an active ingredient, including any Improvements thereto.